Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population
Journal of the Pakistan Medical Association · 2022
DOI: 10.47391/jpma.6154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2022. Verfasst von Tabinda Najeeb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Baqai Medical University, Karachi,Pakistan. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Insulin Resistance.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To evaluate the impact of hepcidin and ferritin in pathogenesis and prognosis of type 2 diabetes mellitus subjects taking only metformin or combined anti-glycaemic agents.
Methods
The observational case-control study was conducted at the Department of Physiology, Baqai Medical University, Karachi, from August 2019 to October 2020, and comprised subjects from both genders who categorised into equal groups as non-diabetic controls, newly-diagnosed type 2 diabetes mellitus patients without any treatment, type 2 diabetes mellitus patients with exposure to metformin only, type 2 diabetes mellitus patients taking oral hypoglycaemic agents along with metformin, type 2 diabetes mellitus patients taking only insulin, and type 2 diabetes mellitus patients taking insulin and oral hypoglycaemic agents. Fasting plasma glucose was determined using glucose oxidase-peroxidase method, glycated haemoglobin by high performance liquid chromatography, high-density lipoprotein and low-density lipoprotein by direct methods, cholesterol by cholesterol oxidase phenol 4-amino antipyrine peroxidase and triglycerides by glycerol phosphate oxidase-phenol 4-amino antipyrine peroxidase method. Serum levels of ferritin, insulin and hepcidin were evaluated using Enzyme-linked immunosorbent assay. Insulin resistance was assessed using homeostasis model assessment for insulin resistance. Data was analysed using SPSS 21.
Results
Of the 300 subjects, there were 50(16.66%) in each of the 6 groups. Overall, there were 144(48%) males and 155(51.66%) females. The mean age was significantly lower in the control group 34.72±7.87 compared to all the diabetic groups (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Baqai Medical University, Karachi,Pakistan.
- Department of Physiology, Baqai Medical University, Karachi, Pakistan.
- Departmentof Biochemistry, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi,Pakistan.
- Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan.
- Departmentof Biochemistry, Baqai Medical University, Karachi,Pakistan.
- Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi.
Zitieren
APA
Najeeb, T., Soomro Late, M. S., Fawwad, A., Waris, N., Nangrejo, R., Siddiqui, I. A., Aziz, Q., & Basit, A. (2022). Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.6154
Vancouver
Najeeb T, Soomro Late MS, Fawwad A, Waris N, Nangrejo R, Siddiqui IA, et al. Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population. Journal of the Pakistan Medical Association. 2022. doi:10.47391/jpma.6154
BibTeX
@article{Najeeb2022,
author = {Najeeb, Tabinda and Soomro Late, Mohammad Saleh and Fawwad, Asher and Waris, Nazish and Nangrejo, Ruqaya and Siddiqui, Iftikhar Ahmed and Aziz, Qamar and Basit, Abdul},
title = {Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population},
journal = {Journal of the Pakistan Medical Association},
year = {2022},
doi = {10.47391/jpma.6154}
}
EUVIMED